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Abstract
Analysis of trends in nanotoxicology data and the development of data driven models for nanotoxicity is facilitated by the reporting
of data using a standardised electronic format. ISA-TAB-Nano has been proposed as such a format. However, in order to build
useful datasets according to this format, a variety of issues has to be addressed. These issues include questions regarding exactly
which (meta)data to report and how to report them. The current article discusses some of the challenges associated with the use of
ISA-TAB-Nano and presents a set of resources designed to facilitate the manual creation of ISA-TAB-Nano datasets from the nano-
toxicology literature. These resources were developed within the context of the NanoPUZZLES EU project and include data collec-
tion templates, corresponding business rules that extend the generic ISA-TAB-Nano specification as well as Python code to facili-
tate parsing and integration of these datasets within other nanoinformatics resources. The use of these resources is illustrated by a
“Toy Dataset” presented in the Supporting Information. The strengths and weaknesses of the resources are discussed along with
possible future developments.
Introduction
Nanotechnology, which may be considered the design and
application of engineered nanomaterials with desired properties
[1,2], is of increasing importance [3,4]. Nanomaterials may be
considered to be any chemicals with (a majority of) constituent
particles with one or more dimensions in the nanoscale (typi-
cally 1–100 nm) range and engineered nanomaterials may be
considered to be any nanomaterials that are intentionally
produced. (It should be noted that slightly different definitions
of these terms have been proposed by different organisations [1]
and the European Commission has recommended a specific
definition of a “nanomaterial” for legislative and policy
purposes within the European Union [5].)
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Nanomaterials have been used and/or have been investigated for
use in a diverse range of applications such as sunscreens,
cosmetics, electronics and medical applications [2,4,6,7]. In
addition to interest in the benefits offered by nanotechnology,
concerns have also been raised about the potential risk posed by
nanomaterials to human health and the environment [3,4,7].
Various research initiatives have been (and are being) funded to
advance scientific understanding of nanotechnology and
nanosafety and to enable the appropriate selection, design and
regulation of nanomaterials for technological applications
[3,8,9]. There is a particular interest in the possibility of
using computational approaches as part of the safety assess-
ment of nanomaterials, e.g., to enable “safety by design”
[3,7,9,10].
Experimental data are critical to advancing understanding of the
properties of nanomaterials and the ability to design nanomate-
rials with desirable technological properties and acceptable
safety profiles [2,9-11]. In order to enable “safety by design”,
data from toxicity studies need to be related to relevant struc-
tural/physicochemical data [10], where the latter may include
information about chemical composition as well as a range of
other measured properties such as size distribution statistics and
zeta potential, to name but two [12]. Being able to relate these
data allows for the development of predictive models based on
quantitative structure–activity relationships (QSARs) for
nanomaterials – so-called quantitative nanostructure–activity
relationships (“QNARs”) [10] or “nano-QSARs” [13] – as
well as “category formation” and “read-across” predictions
[9,14,15].
In order to make most effective use of these data, experimental
datasets should be made available via a standardised, electronic
format that facilitates meaningful exchange of information
between different researchers, submission to (web-based)
searchable databases, integration with other electronic data
resources and analysis via appropriate (modelling) software
[9,16-18]. This could entail directly populating files based on a
standardised format or direct entry of data into searchable data-
bases using a (web-based) data entry tool [19], followed via
data export/exchange in a standardised format. However, in
contrast to directly populating standardised, structured files
(such as spreadsheets), direct entry of data into (web-based)
searchable databases may not be possible for domain experts
(e.g., nanotoxicologists in experimental labs) with little or no
informatics support. These researchers may not have their own,
in-house database systems and data entry to a third party data-
base at the point of data collection may not be practical. Data
collected using standardised, structured files may be readily,
programatically submitted to (web-based) searchable databases
at a later stage in the research cycle.
Standardised, structured files also facilitate programmatic anal-
ysis (i.e., entirely new codes and/or configuration files do not
need to be developed for each new dataset) for the purposes of
computational modelling. They also facilitate integration
between datasets, partly due to the ease of programmatic analy-
sis and in part because standardisation makes it clearer when
two items of (meta)data in distinct datasets are related. Data
integration within searchable databases supports computational
modelling via enabling data from multiple sources to be
combined, in principle, for more robust, generalisable analysis
and via facilitating the identification of data which are relevant
to the needs of a given modeller.
Regarding the nature of these standardised, structured files,
whilst more complicated file formats based on the eXtended
Markup Language (XML) or the Resource Description Frame-
work (RDF) might be considered, a spreadsheet-based file
format offers a key advantage: most scientists are likely to be
familiar with creating, editing and viewing spreadsheet-based
datasets [17,20,21]. Indeed, these kinds of files can be edited
and viewed using widely used, non-specialist software (such as
Microsoft Excel), whilst (to some extent) a spreadsheet-like
interface may be retained within specialist software designed to
ensure the files are compliant with the rules of a standardised
specification [17,20,22]. However, no claim is being made as to
the intrinsic optimality of a spreadsheet-based format: a detailed
discussion of the advantages and disadvantages of different file
formats is beyond the scope of the current publication and inter-
ested readers are referred to the cited literature and the refer-
ences therein [17,20,21].
The ISA-TAB-Nano specification, comprising a set of interre-
lated spreadsheet-based tabular file types, was recently
proposed as a solution to the requirement for a standardised,
electronic format for nanomaterial data [16,17,23]. However, as
well as a general specification specifying how different kinds of
(meta)data should be recorded in a standardised fashion, addi-
tional requirements for nanotoxicology datasets to be most valu-
able for analysis of trends and development of data driven
models exist. These requirements include the need to report the
necessary physicochemical parameters, experimental details and
other relevant metadata such as provenance [12,24-27]. Whilst
the generic ISA-TAB-Nano specification [17,23] specifically
calls for relevant provenance information to be provided, and
facilitates presentation of other (meta)data, it does not specify
all of the (meta)data which should be recorded nor exactly how
these (meta)data should be presented.
This article presents a set of resources which were designed for
manually harvesting data from the published literature to create
ISA-TAB-Nano datasets in order to support analysis and model-
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ling of nanotoxicology data, including the integration of these
data within online, searchable databases. Specifically, these
resources are as follows: a collection of Excel templates for
creating ISA-TAB-Nano files containing specific, relevant
(meta)data manually harvested from the scientific literature; a
corresponding set of business rules for populating these tem-
plates which build upon the generic ISA-TAB-Nano specifica-
tion; a Python program for converting the resulting ISA-TAB-
Nano files to tab-delimited text files to facilitate computational
analysis and database submission. Since there is a growing
interest in the use of ISA-TAB-Nano as a community standard
for organising nanomaterial data, from a variety of individual
researchers and organizations [3,28-32], it is anticipated that
these resources will be of value for the research community.
These resources were developed within the context of the Nano-
PUZZLES project [33], but their development was informed via
discussions with various researchers in the nanoinformatics/
nanotoxicology community and consideration of various com-
plementary nanoinformatics resources such as those developed
within the MODERN [34] and eNanoMapper [35] projects.
The rest of the article is organised as follows. Section 1 of
“Results and Discussion” provides a brief overview of the
generic ISA-TAB-Nano specification. Section 2 summarises
some challenges associated with the use of this generic specifi-
cation (especially when used to collect data from the literature),
which the current work sought to address. Section 3 summarises
the data collection templates and the basis on which they were
developed. Section 4 summarises the new business rules which
were created for populating these templates. Section 5 provides
an overview of the Python program written to facilitate analysis
and databases submission of datasets created using these tem-
plates. Section 6 presents a “Toy Dataset” created using these
templates. Section 7 presents a critical appraisal of the devel-
oped resources, discusses links to related research initiatives
and resources along with possible future directions for this
work. The “take home” messages of this article are summarised
under “Conclusion”. The challenges, business rules and notable
limitations of the presented resources (summarised in sections
2, 4 and 7, respectively) are fully explained in the Supporting
Information. The resources described in this article, along with
the “Toy Dataset”, are publicly available under open licenses
(see Supporting Information Files 1–4).
Results and Discussion
1 A brief overview of the generic ISA-TAB-
Nano specification
The ISA-TAB-Nano specification [17,23] extends the ISA-TAB
specification [18,20,22,36] which was previously proposed as
an exchange standard for biological data and metadata based on
a standardised metadata representation. Unless noted otherwise,
the specification incorporates [17,23] all the business rules (e.g.,
restrictions on which fields can hold multiple values) asso-
ciated with the original ISA-TAB specification [36]. The offi-
cial ISA-TAB-Nano wiki [23] provides the most up to date
information regarding the generic ISA-TAB-Nano specification,
including detailed descriptions [37-40] and Excel templates for
each of the file types described below. Since the original
description of the specification in Thomas et al. [17], two revi-
sions (version 1.1 and version 1.2) of the specification had been
published on the wiki at the time of writing. The overview
provided in the current paper refers to version 1.2 of ISA-TAB-
Nano. Since the specification is extensively described else-
where [17,23], the following overview focuses on the essential
background required to understand the following sections of the
current paper.
The ISA-TAB-Nano specification describes a set of four linked
file types (Investigation, Study, Assay, Material), each of which
is a spreadsheet-like table, which are used to record different
kinds of (meta)data associated with a given “investigation”,
which may be considered to correspond to a set of different
kinds of experimental studies carried out on a given set of nano-
materials [36]. In addition, the specification describes corres-
ponding business rules governing how these files can be popu-
lated. A given “investigation” is associated with a single
Investigation file and, potentially, multiple Study, Assay
and Material files. The kinds of (meta)data each file
type is designed to record and the links between different kinds
of files is summarised in Figure 1 and discussed in more detail
below.
Investigation file
The Investigation file [37] reports key metadata describing the
terms used in the other files as well as reporting overall conclu-
sions derived from the “investigation”, if any.
Material file
Each of the nanomaterial samples (implicitly as originally
sourced for the “investigation” [17]) is described by a corres-
ponding Material file [40] associated with a unique identifier
reported in the “Material Source Name” column and used to
label the Material file. A Material file presents chemical com-
position information along with other descriptive information
about the sample such as nominal or manufacturer supplied
characteristics reported via end user defined “Characteristics
[characteristic name]” columns. Since nanomaterials of diverse
types (e.g., dendrimers, carbon nanotubes, surface-coated metal
oxides) may comprise different components (e.g., core and
shell), the initial rows of the Material file are used to describe
the overall nanomaterial sample with subsequent rows used to
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Figure 1: A schematic illustration of the links between ISA-TAB-Nano files. Biological or material samples are prepared for measurements in bio-
logical or physicochemical assays respectively. Assay files link measurement values with prepared sample identifiers (“Sample Name” values). Study
files describe sample preparation. Material files describe the nanomaterials obtained for testing, denoted via their “Material Source Name” identifiers.
N.B. Italic font denotes generic names, e.g., “Factor Value [test material]” is replaced with “Factor Value [nanomaterial]” in the NanoPUZZLES in vitro
cell-based Study file template.
describe the individual components: the overall sample and
different components are each assigned unique values in the
“Material Name” column.
Study file
A Study file [38] describes the preparation of samples for analy-
sis via some assay protocol. The identifiers of prepared samples
are reported in “Sample Name” columns, with sequentially
prepared samples corresponding to identifiers in sequential
“Sample Name” columns, and the identifier(s) of the original
material(s) from which these samples were prepared is (are)
reported in the “Source Name” column. In principle, multiple
“Source Name” identifiers might correspond to one or more
“Sample Name” identifiers [36]. However, in the simplest case
(as adopted in the current work), a single prepared sample
corresponds to a single original material, i.e., each row corre-
sponds to a single “Source Name” and a single “Sample Name”
identifier. Properties associated with the original material or,
more specifically, a prepared sample may be reported via
“Characteristics [characteristic name]” columns situated after
the “Source Name” column or after the relevant “Sample
Name” column respectively. Here, it should be noted that the
properties recorded via these columns should not include
experimental endpoints which would be reported via an Assay
file or other information about original nanomaterial samples
which would be reported via a Material file.
The transformation of the original material into the prepared
sample(s) corresponds to one or more protocols (with corres-
ponding protocol names reported in “Protocol REF” columns),
associated with corresponding protocol “parameters” (reported
in “Parameter Value [parameter name]” columns), and
“factors” (reported in “Factor Value [factor name]” columns).
The concept of “parameters” refers to “variables that are kept
constant in an assay experiment”, whilst the concept of
“factors” refers to “variables that are changed for studying their
effects on the measured endpoint” [17]. If the assay is bio-
logical (e.g., an in vitro cytotoxicity assay), the originally
sourced biological material is considered the original material,
with its identifier reported in the “Source Name” column, from
which a sample is prepared for testing in an assay and the origi-
nally sourced nanomaterial is considered a “factor”, since the
effect of adding this nanomaterial to the biological sample
being prepared for evaluation is studied: the corresponding Ma-
terial file identifier (“Material Source Name”) is reported in an
appropriate “Factor Value [factor name]” column (e.g., “Factor
Value [nanomaterial]). If the assay measures nanomaterial
physicochemical parameters (e.g., size by dynamic light scat-
tering, zeta potential), the originally sourced nanomaterial
sample is considered the original material, i.e., the “Material
Source Name” is reported in the Study file “Source Name”
column. It follows that different Study files must be created for
samples prepared for biological or physicochemical assays.
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Assay file
An Assay file [39] links (a subset of) the prepared samples
described in a given Study file to the experimental measure-
ments, of a given type, obtained in a given assay. Each Assay
file row corresponds to a given sample, with the “Sample
Name” identifier defined in the corresponding Study file being
reported in the Assay file “Sample Name” column. Additional
columns (“Protocol REF”, “Assay Name”, “Parameter Value
[parameter name]”, “Factor Value [factor name]”) in the Assay
file identify the assay protocol performed and experimental
details associated with the production of a given (set of) data
point(s) obtained from that assay for a given sample. (Here, the
concepts of “parameters” and “factors” are as defined above for
the Study file, although Assay file “parameters” are specific to
Assay file protocols and one may choose to report “factors” in
the Assay file if they are applicable to the assay procedure used
to generate data points for a given prepared sample [17,39].)
The corresponding data points are presented in “Measurement
Value [statistic(measurement name)]” columns, e.g., “Measure-
ment Value [z-average(hydrodynamic diameter)]” for an
Assay file describing dynamic light scattering (DLS) size
measurements [41,42].
External files
“External” files [17,36], presenting additional information asso-
ciated with the original nanomaterial samples or assay measure-
ments, can be linked to the appropriate Material and Assay file
respectively via additional columns and may also be included
within the ISA-TAB-Nano dataset.
Support for (meta)data standardisation
The ISA-TAB-Nano specification promotes standardised
reporting of (meta)data in the following ways. (1) It defines a
certain number of fixed fields (rows in the Investigation file, or
columns in the remaining file types). (2) It describes a syntax
for adding additional fields of a given type, e.g., “Parameter
Value [parameter name]” and “Factor Value [factor name]”.
(3) It supports links between terms added by the end user (e.g.,
a parameter name or the unit for a “Measurement Value
[statistic(measurement name)]” column entry) and standardised
definitions retrieved from ontologies. (An excellent introduc-
tion to ontologies can be found in the recent articles of Thomas
et al. [2,11] along with an overview of a highly relevant
example: the NanoParticle Ontology (NPO) [2].) (4) It supports
links to standardised protocol documentation, for sample
preparation or assay measurements, for protocol names
reported in “Protocol REF” columns in a Study or Assay file.
(The ontologies to which various terms are linked are
defined using fields in the Investigation file, which also
provides links between protocol names and standardised
documentation.)
As well as providing some pre-defined fields and stipulating a
specific syntax for adding fields of a specific type (e.g., “Factor
Value [factor name]”), miscellaneous additional fields can be
created via adding new “Comment [name of (meta)data item]”
fields if no appropriate alternative exists.
2 Challenges associated with the generic
ISA-TAB-Nano Specification which were
addressed in the current Work
Table 1 presents some key challenges associated with the use of
the generic ISA-TAB-Nano specification (version 1.2), espe-
cially when used to collect data from the published literature,
and which were addressed in the work reported in the current
article. An in-depth explanation of these challenges, along with
a detailed discussion of the manner in which they were
addressed via the use of the templates and business rules
summarised in sections 3 and 4, respectively, is provided in
Supporting Information File 4. It should be noted that not all of
these challenges are specific to ISA-TAB-Nano, i.e., some of
them might be encountered when collecting data from the litera-
ture using other formats, and by no means are all of these chal-
lenges specific to collection of data from the published litera-
ture, i.e., some of them might be encountered when trying to
report primary experimental data according to the generic ISA-
TAB-Nano specification. It should also be noted that not all of
these challenges are necessarily within the scope of the generic
ISA-TAB-Nano specification to resolve, e.g., the definition of
appropriate minimum information criteria. The need to address
these challenges informed the design of the templates discussed
in section 3 and the accompanying business rules, summarised
in section 4 and presented in full in Supporting Information
File 4, which were applied for the purpose of data collection
from the nanotoxicology literature within the NanoPUZZLES
EU project. It should be noted that no claim is made that all of
these challenges are perfectly addressed via use of the resources
presented in the current publication. The strengths and weak-
nesses of the manner in which these issues are addressed via the
templates and business rules developed within NanoPUZZLES
are discussed in the context of the detailed explanation of these
challenges, which is presented in Supporting Information File 4.
In addition, some of these challenges are returned to in the
context of considering notable limitations of the resources
developed within NanoPUZZLES. These notable limitations are
summarised in section 7 and discussed in detail in Supporting
Information File 4.
3 NanoPUZZLES data collection templates
General overview of templates
These templates were developed within the NanoPUZZLES
project [33] and were specifically designed for collection of
nanotoxicology data from the literature to support analysis of
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Table 1: Summary of challenges with the generic ISA-TAB-Nano specification which were addressed in the current work.
no. challenge Applicable, in principle, to any format
rather than being specific to ISA-TAB
or ISA-TAB-Nano?
Applicable to
ISA-TAB?
Applicable to
ISA-TAB-Nano?
1 Standardised reporting of stepwise sample
preparation needs to be established.
× × ×
2 Ambiguity exists regarding where different kinds
of information should be recorded.
— × ×
3 Standardised recording of imprecisely reported
experimental variables and measurements is
required.
× × ×
4 Ambiguity exists regarding the creation of
“Comment […]” fields.
× × ×
5 Statistical terms need to be clearly defined. × ×a ×a
6 Ambiguity exists regarding how to link to terms
from ontologies.
— — ×
7 Ambiguity exists regarding whether or not
“Parameter Value” or “Factor Value” column
entries must be constant or not constant
respectively.
— × ×
8 Linking to images reported in publications is
challenging.
× × ×
9 Standardised reporting of multiple component
“characteristics”, “factors”, and “parameters”
(e.g. mixtures) needs to be established.
— × ×
10 A standardised means of linking multiple
“external” files to a given Material file is
required.
— — ×
11 Greater clarity regarding the existence of
“unused” factors, parameters and measurement
names in the Investigation file is required.
— ×a ×
12 A standardised approach for dealing with
“non-applicable” metadata is required.
× × ×
13 The concept of an “investigation” should be
more tightly defined for the purpose of collecting
data from the literature.
— — ×
14 Clearly defined minimum information criteria are
required.
× × ×
aIt should be noted that ISA-TAB is not designed to record experimental measurements in Assay files, i.e., the “Measurement Value
[statistic(measurement name)]” Assay file columns and the corresponding Investigation file “Study Assay Measurement Name” field are an ISA-TAB-
Nano extension [17,37,39]. However, regarding the issue of clearly defining statistical terms (challenge no. 5), ISA-TAB datasets may include
“external” data files (i.e., “external” to the basic Investigation, Study and Assay file types) such as “data matrix” files which may include statistical
terms such as “p-value” [36,43]. Standardisation of statistical terms may be achieved via using terms from the STATistics Ontology (STATO) [44]. The
challenge noted here (challenge no. 5) regarding clearly defining statistical terms concerns how to appropriately create links to ontologies for these
terms in ISA-TAB-Nano datasets.
trends and the development of data driven computational
models such as nano-QSARs. These templates are available
from the myExperiment online repository [45,46]: file entry
“NanoPUZZLES ISA-TAB-Nano Templates” [47]. Version 3
of this file entry corresponds to the version of the templates
referred to in the current publication and any corrections and/or
extensions of these templates will also be made publicly avail-
able via future versions of this file entry.
The motivation for employing non-generic templates, designed
to record specific kinds of (meta)data of interest to specific
researchers, as opposed to generic templates that merely indi-
cate the kinds of fields which the four ISA-TAB-Nano file types
(Investigation, Study, Assay, Material) can contain, is that
specific files with specific fields would need to be created at the
point of data collection in any case but creating these specific
files “on-the-fly” (i.e., at the point of data collection) is prob-
lematic. For example, a generic Assay file template would only
indicate that certain, unspecified, experimental variables and
endpoint values should be recorded using “Parameter Value
[…]” (or other column type such as “Factor Value […]”) and
“Measurement Value […]” columns, respectively. However,
when collecting certain kinds of data obtained with a given
assay, a specific Assay file with specific “Measurement Value
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[…]” and “Parameter Value […]”columns (or other column
types such as “Factor Value […]”) would need to be created to
record the (meta)data of interest. Indeed, the Investigation file is
designed to associate a given “Study Assay Measurement Type”
(e.g., size) and “Study Assay Technology Type” (e.g., dynamic
light scattering) with a given “Study Assay File Name”. Hence,
specific templates (such as those developed in the current work)
serve two important purposes: (a) they avoid the end user
having to decide which specific fields, of a given type, should
be created to record specific items of (meta)data; (b) they
communicate to the end user which items of (meta)data should
be reported in the dataset, i.e., they effectively define minimum
information criteria. However, in case the specific templates do
not capture all the experimental (meta)data of interest to a given
end user of the dataset, it is important to recognise that the tem-
plates may be updated with new fields (in existing templates) or
additional specific templates may be created.
The templates developed in the current work were adapted from
generic Excel templates made available by the ISA-TAB-Nano
developers [23]. The templates presented in this publication are
designed to be compatible with version 1.2 of the ISA-TAB-
Nano specification [23]. The generic templates were adapted as
follows.
1. Predefined “Comment […]” fields were added to the Investi-
gation file template for recording additional important metadata,
e.g., “Comment [GLP]” for recording whether or not the corres-
ponding studies were carried out according to Good Laboratory
Practice [27,48].
2. Two specific Study file templates were created for sample
preparation prior to physiochemical or cell based in vitro
assays. (A Study file for sample preparation prior to in vivo
assays was under development at the time of writing.)
3. Specific Assay file templates were created for (a) different
kinds of physiochemical measurements and, in some cases, (b)
for specific assays which might be employed to make those
measurements. In some cases, where scenario (b) was not
applicable, generic “Measurement Value [statistic(measure-
ment name)]” columns were created with the statistic and/or
measurement name presented as a generic “[TO DO: ….]”
label: these labels should be replaced, as required, with specific
statistic and measurement name values during data collection
(as documented in the templates) or columns with these generic
headings should be deleted if not applicable. For example, an
Assay file template was designed for recording size
measurements from a non-predetermined assay type
(“a_InvID_PC_size_Method.xls”) in addition to some Assay
file templates for recording size measurements obtained using
specific assay types - such as dynamic light scattering (DLS)
(“a_InvID_PC_size_DLS.xls”) [41,42]. The former template
(“a_InvID_PC_size_Method.xls”) includes the column
“Measurement Value [[TO DO: appropriate average]([TO DO:
appropriate size measurement])]”: this would be updated to
“Measurement Value [mean of the number distribution(diam-
eter)]”, to give but one possible example, during dataset
creation. The latter template (“a_InvID_PC_size_DLS.xls”)
includes the columns “Measurement Value [z-average (hydro-
dynamic diameter)]” and “Measurement Value [polydispersity
index]”.
4. Specific Assay file templates were created for recording toxi-
city data for endpoints that were prioritised within the Nano-
PUZZLES project.
5. Predefined “Characteristics […]”, “Factor Value […]” and
“Parameter Value […]” columns were added to these Study and
Assay file templates based upon consideration of which experi-
mental variables were expected to affect the associated assay
measurements. For example, the Study template for cell based
in vitro studies (“s_InvID_InVitro.CB.xls”) includes the
predefined columns “Characteristics [cell type {EFO:http://
www.ebi.ac.uk/efo/EFO_0000324}]” and “Factor Value [expo-
sure medium]”.
6. Predefined “Characteristics […]” columns were added to the
Material file template for recording important chemical com-
position information, beyond that specified in the generic tem-
plates, along with nominal/vendor supplied values of various
other physicochemical parameters, e.g., “Characteristics [Pro-
duct impurities found {MEDDRA:http://purl.bioontology.org/
ontology/MDR/10069178}]”, “Characteristics [Major crys-
talline phase]” and “Characteristics [average size]”.
7. Predefined “Comment […]” columns were added to the Ma-
terial, Study and Assay file templates for recording key meta-
data that could (a) assist in interpreting the results or (b) allow
the quality of the results to be assessed. For example, the
template “a_InvID_PC_size_TEM.xls” for recording size by
transmission electron microscopy (TEM) contains the columns
“Comment [primary particle measurements]” and “Comment
[size: from graph]” to address requirements of type (a) and (b)
respectively. The “Comment [primary particle measurements]”
column was designed to report whether or not the size measure-
ments obtained were explicitly stated, in the publication from
which they were extracted, to have been made for the primary
particles: in principle, TEM might be used to provide informa-
tion about agglomerates, aggregates or primary (individual)
particles for a given prepared sample [49,50]. The “Comment
[size: from graph]” column was predicated on the assumption
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that data extracted from graphs (which are not uncommon when
collecting data from the literature) are less reliable (i.e. more
prone to transcription errors) than data extracted from tables or
text.
8. For some fields, drop-down lists with possible field entries
were created using the “Data Validation” option in Excel 2010.
9. The fields were colour coded to indicate those fields which
were judged to be essential (green), desirable (yellow) or not
important for the purposes of the NanoPUZZLES project (red).
10. Some fields (e.g., the Material file “Material Design Ratio-
nale” column) which were not considered important for the
purposes of the NanoPUZZLES project were simply deleted.
11. Detailed comments were added (via the Excel 2010
“Review” tab) describing how different predefined fields should
be populated during data collection.
12. The fields in the Investigation template (“i_InvID.xls”) were
populated insofar as possible prior to data collection. This
included specifying predefined “factors” and “parameters” (c.f.
other templates) and defining a set of ontologies from which
terms should (preferentially) be obtained during data collection.
13. Some of the fields in the templates were populated with
indicated values where appropriate. In some cases, these indica-
tions might actually be literally entered as values for the corres-
ponding field entries, e.g., “size determination by DLS”
entered in the first row of the “Protocol REF” column in the
“a_InvID_PC_size_DLS.xls” template. However, in other
cases, the suggested entries should not be entered literally,
e.g., “size determination by <Assay technology type>”
en te red  in  the  f i r s t  row of  the  “Pro toco l  REF”
c o l u m n  i n  t h e  “ a _ I n v I D _ P C _ s i z e _ M e t h o d . x l s ”
template, where “<Assay technology type>” would be
replaced with the name of the relevant method, such as
“environmental scanning electron microscopy” [51,52] for the
Assay file (“a_TOY.article_PC_size_ESEM.xls”) in the
“Toy Dataset” (see section 6) derived from the template
“a_InvID_PC_size_Method.xls”.
14. NanoPUZZLES specific naming conventions were estab-
lished (as suggestions, rather than business rules) for creating
files based on these templates. For example, “InvID” denotes
“Investigation Identifier” and “Method” denotes an assay
measurement technique such as dynamic light scattering (DLS).
1 5 .  A  n e w  “ I m a g e L i n k ”  t e m p l a t e  w a s  c r e a t e d
(“ImageLink_NUMBER_for_InvID.xls”) for linking to images
reported in publications which are not associated with a single
file that can be redistributed as part of a dataset or uniform
resource identifier (URI). The use of this template is defined by
NanoPUZZLES business rule no. 18 (see section 4 and
Supporting Information File 4).
Identification of important experimental variables
and characterisation data
The experimental variables (for both toxicological and physico-
chemical assays) and types of physicochemical characterisation
data which the templates were designed to capture were based
upon considering the well-known MINChar Initiative Parame-
ters List [53], the provisional recommendations developed
within the NanoSafety Cluster Databases Working Group [26],
other resources developed within the context of the NanoSafety
Cluster projects PreNanoTox [54] and MARINA [55] as well as
discussions with nanotoxicology researchers and consideration
of the published literature regarding toxicologically significant
physicochemical characterisation parameters (for nanomate-
rials) and experimental variables which could significantly
affect toxicological or physicochemical measurements
[10,12,49,56-63]. However, no claim is made that the templates
developed to date within the NanoPUZZLES project would
capture all of the experimental variables or relevant characteri-
sation information indicated by the cited proposals or otherwise
recognised as important in the nanotoxicology community.
Physicochemical characterisation data captured by
the templates
The categories of physicochemical information these templates
were designed to capture, along with the corresponding Ma-
terial and/or Assay file templates, are summarised in Table 2. In
keeping with the generic ISA-TAB-Nano specification (version
1.2) [64], information which could be recorded using an Assay
file template (“a_.....xls”) should only be recorded using the
Material file template (“m_MaterialSourceName.xls”) if its
value was nominal or vendor supplied.
These categories of physicochemical information correspond to
all of the kinds of physicochemical information highlighted as
being important in the MINChar Initiative Parameters List [53],
with the context dependence stressed by this initiative being
(partially) captured via recording sample conditions using
“Factor Value […]” columns in the physicochemical Study file
template (“s_InvID_PC.xls”), e.g., “Factor Value [medium]”.
In order to construct these templates, careful consideration was
required of exactly how to record different kinds of physico-
chemical information highlighted as being important. Firstly,
this required consideration of which measurements might
correspond to different kinds of physicochemical information;
Beilstein J. Nanotechnol. 2015, 6, 1978–1999.
1986
Table 2: Categories of physicochemical information which the NanoPUZZLES ISA-TAB-Nano templates were designed to capture.
category template(s) comments
chemical composition
(including surface
composition, purity and
levels of impurities)
“m_MaterialSourceName.xls” Only chemical composition information associated with the
original / vendor supplied nanomaterial should be reported
here, i.e., not adsorption data (see below).
crystal structure/
crystallinity
“m_MaterialSourceName.xls”;
“a_InvID_PC_crystallinity_Method.xls”
—
shape “m_MaterialSourceName.xls”;
“a_InvID_PC_shape_Method.xls”
Both qualitative descriptions of shape or “aspect ratio” data
[60] can be recorded.
particle size/
size distribution
“m_MaterialSourceName.xls”;
“a_InvID_PC_size_Method.xls”;
“a_InvID_PC_size_DLS.xls”;
“a_InvID_PC_size_TEM.xls”
Dynamic light scattering (DLS) [41] or transmission electron
microscopy (TEM) [65,66] measurements are captured
using the indicated Assay file templates. Otherwise, unless
size values are nominal/vendor supplied, size
measurements are captured via the generic Assay file
template.
surface area “m_MaterialSourceName.xls”;
“a_InvID_PC_surface area_Method.xls”
This was designed to record “specific surface area” values,
i.e., surface area per unit mass [58].
surface charge/
zeta potential
“m_MaterialSourceName.xls”;
“a_InvID_PC_zetapotential_Method.xls”
Zeta potential is commonly used as a proxy for surface
charge [58].
adsorption “a_InvID_PC_adsorption_Method.xls” This was designed to record “adsorption constants” [57] and
(equilibrium) adsorption percentages [67] for specific small
molecule / macromolecular “probe” species.
reactivity “a_InvID_PC_reactivity.rateofchange_of.
X_SeparationTechnique_Method.xls”
The design of this template reflects the fact that, for some
reactivity assays, the analysed species needs to be
removed prior to making measurements [68].
dissolution (1)
“a_InvID_PC_dissolution.conc_of.X_Sepa
rationTechnique_Method.xls” ;
(2)
“a_InvID_PC_dissolution.fraction-dissolve
d_SeparationTechnique_Method.xls”;
(3)
“a_InvID_PC_dissolution.rate_of.X_Separ
ationTechnique_Method.xls”
The design of these templates reflects the fact that a
number of different kinds of dissolution measurement may
be made for inorganic nanoparticles: (1) the (time
dependent) concentrations of various species released by
dissolution [67,69] (which may be a redox process [69]); (2)
the (time dependent) percentage of original nanoparticles
dissolved [70]; (3) the (time dependent) dissolution rate [71].
The design of these templates further reflects the fact that
dissolution assay protocols typically employ a separation
step to isolate the analysed species [61].
molecular solubility “a_InvID_PC_solubility_Method.xls” In the current context, the Chemical Methods Ontology
definition of “solubility” [72] was used: “the concentration of
a solute in a saturated solution”. This Assay template was
specifically designed for recording molecular “solubility”
measurements, e.g., the solubility of fullerene nanoparticles
[73].
agglomeration/
aggregation
“a_InvID_PC_AAN_BETapproach.xls” This template was designed for recording the “average
agglomeration number” derived from BET gas adsorption
data, size measurements and particle density values
[58,74]. However, it should be noted that recording of size
information obtained under different experimental conditions
(using the Assay file templates noted above) may also
convey information about the agglomeration state [58]. In
addition, a number of physicochemical Assay files (e.g.
“a_InvID_PC_size_Method.xls”) contain “Comment […]”
columns (e.g., “Comment[primary particle measurements]”)
designed to record whether or not the reported data are
noted to refer to the primary particles (as opposed to
agglomerates and/or aggregates) by the authors of the
reference from which the data were extracted.
hydrophobicity “m_MaterialSourceName.xls”;
“a_InvID_PC_logP_Method.xls”
—
the “minimum” characterisation parameters reported in various
proposals [12,53] are sometimes quite broadly defined, e.g.,
“Surface Chemistry, including reactivity, hydrophobicity” [53].
Secondly, this required consideration of which corresponding
Material file “Characteristics […]” and/or Assay file “Measure-
ment Value […]” columns needed to be defined - as well as, in
some cases, which “Parameter Value […]” columns needed to
be defined, e.g., “Parameter Value [analyte role]” (i.e., the
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dissolved species being measured) for dissolution Assay file
templates. No claim is made that the templates developed to
date within the NanoPUZZLES project would capture all rele-
vant measurements which might be associated with a given
category of physicochemical information listed in Table 2.
Experimental variables captured by the templates
The experimental variables associated with sample preparation
prior to applying assay protocols for (1) physicochemical
measurements (see above) or (2) cell based in vitro toxicolog-
ical assays are principally described via “Factor Value […]”
columns in two Study file templates: (1) “s_InvID_PC.xls”, (2)
“s_InvID_InVitro.CB.xls”.
For physicochemical studies, these “Factor Value […]”
columns record the values of experimental variables associated
with the preparation of a nanomaterial sample prior to applica-
tion of an assay protocol, e.g., “Factor Value [physical state]”
(for recording whether or not the sample was prepared as a
suspension or a powder), “Factor Value [medium]” (for
recording the suspension medium, i.e., not applicable if the
“physical state” is a powder), “Factor Value [Sonication]” (for
recording whether or not the sample was sonicated [49]).
For cell-based in vitro studies, these “Factor Value […]”
columns record the values of experimental variables associated
with preparation of the composite sample being tested, i.e., the
nanomaterial suspension and the biological component on
which the effect of the nanomaterial will be evaluated. Hence,
they are designed to capture different kinds of experimental
variables: (1) those which are relevant to preparation of the bio-
logical sample prior to adding the nanomaterial, e.g., the
“Factor Value [culture medium glucose supplement]” in
“s_InvID_InVitro.CB.xls” designed to record whether or not
the cells were grown in glucose containing “culture medium”,
which may significantly affect the observed toxicity in some in
vitro assays [56]; (2) those which are relevant to the prepar-
ation of the nanomaterial sample applied to the biological
sample, e.g., “Factor Value [exposure medium]” and “Factor
Value [Sonication]” for capturing the “exposure medium” for
an in vitro (cell-based) study (otherwise known as the “expo-
sure media” [75,76], i.e., the liquid mixture via which the tested
chemical – a nanomaterial in the current context - reaches the
cells) and whether or not sonication was applied to the tested
nanomaterial suspension respectively; (3) those which are rele-
vant to the combined sample to which the assay protocol is
applied, e.g., “Factor Value [cells Exposure Duration]”.
Capturing of the experimental conditions under which corres-
ponding physicochemical characterisation and toxicity data
were generated is important to assess whether or not characteri-
sation was performed under biologically relevant conditions
[77]. For example, whether or not a given size measurement
was performed in the same suspension medium used for an in
vitro (cell-based) study might be determined via comparing the
“Factor Value [medium]” and “Factor Value [exposure
medium]” entries in the physicochemical and in vitro (cell-
based) Study files, respectively. However, details regarding
possible suspension medium additives – such as serum and
dispersant aids [78] – would need to be compared with each
other by comparing the values in additional “Factor Value […]”
fields.
In addition, for the “s_InvID_InVitro.CB.xls” Study file
template, “Characteristics […]” columns associated with the
“Source Name” column (i.e., positioned after the “Source
Name” column but before the “Sample Name” column) are
used to describe experimental variables which are inherent to
the biological specimen: "cell type”, “cell line”, “organism” and
“strain”, as defined in the Experimental Factor Ontology (EFO)
[79,80].
Experimental variables specifically associated with assay proto-
cols are recorded in Assay files, principally using “Parameter
Value […]” columns, e.g., “Parameter Value [Instrument]”,
“Parameter Value [negative control]”.
It should be noted that the manner in which some of these
experimental variables are captured via these templates might
be carried out differently by other researchers and may deviate
from the expectations of the generic ISA-TAB(-Nano) specifi-
cation [17,23,36]. Some of the “Factor Value […]” columns
(e.g., “Factor Value [physical state]” or “Factor Value [final cell
density]” in “s_InvID_PC.xls” and “s_InvID_InVitro.CB.xls”
respectively) might be considered to refer to characteristics of
the prepared sample. Hence, these kinds of variables might else-
where be recorded using “Characteristics […]” columns asso-
ciated with the “Sample Name” column, i.e., positioned after
the “Sample Name” column [36]. Other variables recorded via
“Factor Value […]” columns (e.g., “Factor Value [Sonication
Duration]”) might be kept constant in some experiments [81],
hence could be considered protocol parameters which would be
recorded using “Parameter Value […]” columns [17]. However,
the use of “Factor Value […]” columns to record these latter
variables was deemed appropriate to account for scenarios in
which these variables (e.g., sonication duration) were varied to
assess their effect on assay measurements [49]. The fact that
certain kinds of variables might be considered, in keeping with
the generic ISA-TAB-Nano specification [17] discussed in
section 1, “parameters” in one set of experiments and “factors”
in another depending upon whether or not they were kept
constant or varied to study their effects on the assay measure-
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ment values does not lend itself to consistently organising these
experimental variables in predefined template columns as
developed in the current work.
The potential ambiguity associated with how to record different
experimental variables can be illustrated by considering differ-
ences between the NanoPUZZLES ISA-TAB-Nano [47] and
ToxBank ISA-TAB templates [82,83]: (1) the NanoPUZZLES
Study file template “s_InvID_InVitro.CB.xls” contains the
column “Factor Value [exposure medium]” for describing the
suspension medium via which a tested nanomaterial is applied
to the cells in an in vitro study, whereas the ToxBank Study file
template “studySample.xml” contains the column "Characteris-
tics[vehicle]" for describing the medium used to dilute a tested
compound in an in vitro, in vivo or ex vivo study; (2) the Nano-
PUZZLES Assay file templates treat the identity of assay
controls as “Parameter Value […]” entries (e.g., “Parameter
Value [negative control]”), whereas the ToxBank Study
file template uses a “Characteristics […]” column ("Character-
istics[control]") to assign negative or positive control status to
different samples.
Toxicity data captured by the templates
Assay file templates were developed to capture toxicity
data associated with two toxicological endpoints which were
initially prioritised within the NanoPUZZLES project: cytotoxi-
city (“a_InvID_cytotoxicity.cell-viability_Method.xls”,
“a_InvID_cytotoxicity.sub-lethal_Method.xls”) and genotoxi-
city (“a_InvID_genotoxicity_Method.xls”). Cytotoxicity and
genotoxicity are amongst the endpoints which are frequently
considered when evaluating metal oxide nanoparticles in cell-
based in vitro assays [4,84]. A number of nano-QSAR models
have been developed for cytotoxicity [13,85-91] and some
models have also been developed for nanomaterial genotoxicity
[9,92,93].
T h e  g e n o t o x i c i t y  A s s a y  f i l e  t e m p l a t e
(“a_InvID_genotoxicity_Method.xls”) was designed to capture
the most important outputs from different kinds of genotoxicity
tests. Specifically, the “Parameter Value [Biomarker]” was
designed to record the, test specific, biomarker whose increase
relative to control values (“Measurement Value [mean(increase
in biomarker level)]”) would be determined for nanomaterial
exposed samples. For example, “Parameter Value [Biomarker]”
might report “micronuclei” or “number of revertants” if the
method employed was the micronucleus test [94] or Ames test
[95,96] respectively.
Since the results obtained for different sample preparation
conditions (e.g., different tested concentrations) are usually
used to derive an overall genotoxicity study call (i.e.,
“positive”, “negative” or “equivocal”) [94,96], a corresponding
“Measurement Value [study call]” was added. Values in this
latter column should be associated with “derived sample” iden-
tifiers as introduced in NanoPUZZLES business rule no. 10
(see section 4 and Supporting Information File 4 for an in-depth
explanation).
The lethal cytotoxicity Assay file template (“a_InvID_cytotoxi-
city.cell-viability_Method.xls”) was designed to record data
corresponding to a reduction in cell “viability” (typically inter-
preted as an increase in “cell death”) obtained from cell based in
vitro assays such as MTT, MTS, LDH, and colony forming unit
(CFU) counting [97-99]. The “percent cytotoxicity” columns
(“Measurement Value [mean(percent cytotoxicity)]”, “Measure-
ment Value [standard deviation(percent cytotoxicity)]”) are
designed to record the “percent cytotoxicity” (a measure of cell
death relative to controls equal to 100 – “percent viability”)
[100] associated with specific sample preparations, i.e., a
specific value for the administered concentration or dose [101].
Other “Measurement Value […]” columns were designed to
record measures of cytotoxicity derived from dose (or concen-
tration) response relationships: the lowest observed effect level
(LOEL) [102] (used, in the current work, to denote the lowest
concentration/dose at which significant cell death relative to
controls is observed), the LC50 [103] and LD50 [104], i.e., the
concentration and dose, respectively, which, in the current
context, kills 50% of the treated cells relative to controls.
Values in these latter columns should be associated with
“derived sample” identifiers as introduced in NanoPUZZLES
business rule no. 10 (see section 4 and Supporting Information
File 4 for an in-depth explanation).
The sub-lethal cytotoxicity Assay file template (“a_InvID_cyto-
toxicity.sub-lethal_Method.xls”) was designed to record data
from cell based in vitro assays designed to detect sub-lethal
phenomena which might be quantified in terms of changes in
key biomarkers. For example, oxidative stress and inflamma-
tion might be detected via measuring the level of glutathione or
various cytokine biomarkers respectively [97]. (These sub-
lethal phenomena would not be considered “cytotoxicity” by all
researchers [84].) The manner in which this template was
designed to capture sub-lethal cytotoxicity data is similar to the
design of the genotoxicity Assay file template discussed above:
the “Parameter Value [Biomarker]” column entries would state,
for example, “glutathione” (depending upon the assay), with
“Measurement Value […]” columns recording the “increase in
biomarker level” (relative to control) as well as the LOEL [102]
if this is reported. Values in this latter column should be asso-
ciated with “derived sample” identifiers as introduced in Nano-
PUZZLES business rule no. 10 (see section 4 and Supporting
Information File 4 for an in-depth explanation).
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4 NanoPUZZLES business rules
Within the NanoPUZZLES project [33], a number of project
specific business rules were created for the purpose of speci-
fying how the ISA-TAB-Nano templates described in section 3
should be populated with data from literature sources. As noted
in section 2, and fully explained in Supporting Information
File 4, some of these business rules were specifically designed
to address challenges associated with the generic ISA-TAB-
Nano specification. A summary of these business rules is
provided in Table 3. Supporting Information File 4 presents
detailed explanations of how these business rules should be
applied and, where appropriate, considers their strengths and
weaknesses compared to possible alternatives which might be
applied in future work.
These new rules were applied in addition to the rules which are
part of the generic ISA-TAB-Nano specification as of version
1.2 [17,23,36-40]. (The new rules took precedence over the
generic specification in case of conflicts.) It should also be
remembered that additional guidance on creating ISA-TAB-
Nano datasets using these templates is provided in section 3 and
that guidance on populating individual fields is provided in the
Excel-created comments linked to specific column titles.
Finally, in keeping with the generic specification, the Investi-
gation file and all corresponding files (Study, Assay and Ma-
terial files along with all external files when applicable), for a
single dataset, were added to a single, flat compressed ZIP
archive (see section 5).
5 NanoPUZZLES Python program to
facilitate computational analysis and
database submission
Excel-based ISA-TAB-Nano templates are presented in this
publication and elsewhere [17,23]. However, ISA-TAB-Nano
files (Investigation, Study, Assay, Material) are commonly
implemented in tab-delimited text format [105], reflecting the
fact that ISA-TAB-Nano is an extension of ISA-TAB and ISA-
TAB is intended to be implemented using tab-delimited text
files (Investigation, Study, Assay) [36]. The authors of the
current publication are unaware of any software specifically
designed for parsing ISA-TAB datasets [22,82,106], which
might be extended to parse ISA-TAB-Nano datasets, or soft-
ware specifically designed for parsing ISA-TAB-Nano datasets
[107,108], which does not require the key file types (Investi-
gation, Study, Assay and, for ISA-TAB-Nano, Material) to be
represented in tab-delimited text format. This includes publicly
available online resources recently developed within the context
of the MODERN project [107]: an ISA-TAB-Nano dataset vali-
dator and “Nanomaterial Data Management System”
(“nanoDMS”) – with the latter program implementing a web-
based, searchable database system which is able to, amongst
other functionality, import validated ISA-TAB-Nano datasets
[30,109,110].
To facilitate database submission and other computational anal-
ysis, a Python [111] program was written, within the context of
the NanoPUZZLES project, to enable automated conversion of
an ISA-TAB-Nano dataset prepared using Excel-based tem-
plates to a tab-delimited text version of this dataset. Specifi-
cally, this program was designed to take a flat, compressed ZIP
archive (e.g., “Investigation Identifier.zip”) containing Excel
(“xls”) versions of an Investigation file, plus corresponding
Study, Assay and Material files, and convert this to a flat,
compressed ZIP archive (e.g., “Investigation Identifier-txt.zip”)
containing tab-delimited text versions of these files. Any
external Excel-based “xls” files (e.g., “ImageLink” files intro-
duced in the current work) contained in the archive will also be
converted to tab-delimited text files and other external files will
be transferred to the new archive without modification.
The program has four Open Source dependencies: a Python
interpreter [111] along with the xlrd, xlwt [112] and unicodecsv
[113] Python modules. For the purposes of code development,
Python version 2.7.3, xlrd version 0.93, xlwt version 0.7.5 and
unicodecsv version 0.9.4 were employed. All code was tested
on a platform running Windows 7. The program does not have a
graphical user interface (GUI): input is specified from the
command prompt, e.g., “python xls2txtISA.NANO.archive.py
–i InvestigationID.zip”. The source code and documentation are
available via the “xls2txtISA.NANO.archive” project on
GitHub [114]. Version 1.2 of the program is referred to in the
current publication [115].
Figure 2 provides an overview of the functionality of the
program. As part of converting from Excel-based to tab-delim-
ited text versions of ISA-TAB-Nano files, this program carries
out basic checks on the datasets (e.g., checking for the presence
of at least one file of type Investigation, Study, Assay, Material)
and attempts to correct for basic potential errors in the file
contents (e.g., removing line endings inside field entries) which
might be introduced when manually preparing ISA-TAB-Nano
files using Excel templates. However, the program does not
carry out any sophisticated “parsing” of the datasets, i.e., no
attempt is made to interpret the data in terms of the meaning of
individual fields or the contents of individual field entries. No
checks are carried out on the consistency of different files.
Issues such as case sensitivity, null values and special charac-
ters (beyond removing internal line endings) are not addressed.
Nonetheless, by facilitating conversion to tab-delimited text
format, this enables the datasets to be parsed via more sophisti-
cated tools such as those developed for validating ISA-TAB-
Nano datasets within the MODERN project [107,108].
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Table 3: Summary of the NanoPUZZLES business rules.
business
rule no.
short description
1 A new “investigation” (corresponding to a new dataset comprising a single Investigation file, a set of Study, Assay and
Material files and any “external” files if applicable) should be created for each reference (e.g., journal article), unless
that reference specifically states that additional information regarding experiments on the same original nanomaterial
samples was reported in another reference.
2 The “Factor Value […]” columns in the Study file refer to those values which are applicable to the sample prepared
immediately prior to application of an assay protocol.
3 If the entry for a “Characteristics […]”, “Factor Value […]” or “Parameter Value […]” column corresponds to multiple
components (e.g., mixtures), record this as a semicolon (“;”) delimited list of the separate components.
4 If the entry for a “Characteristics […]”, “Factor Value […]” or “Parameter Value […]” column corresponds to multiple
components, record the entries in corresponding columns as a semicolon (“;”) delimited list with the entries in the
corresponding order.
5 Any intrinsic chemical composition information associated with a nanomaterial sample (as originally sourced) should
be recorded using a Material file even if it is determined/confirmed using assay measurements reported in the
publication from which the data were extracted.
6 Any suspension medium associated with the nanomaterial sample (as originally sourced) should only be described
using a Material file “Material Description” column.
7 Any impurities should be described using entries in the relevant Material file “Characteristics [….]” columns.
8 Any original nanomaterial components, which are neither a suspension medium nor described as “impurities” in the
reference from which the data are extracted, should be described using separate rows of the Material file as per the
generic ISA-TAB-Nano specification.
9 All “Sample Name” values for “true samples” should have the following form: “s_[Study Identifier]_[x]”, e.g., “s_[Study
Identifier]_1”a
10 Assay file “Measurement Value […]” column entries which correspond to concentration-response curve statistics, or
similarly derived measures, should be associated with a “derived sample” identifier rather than a “true sample”
identifier.
11 Imprecisely reported experimental variables should be reported using “Factor Value [statistic(original factor name)]”
columns created “on-the-fly”.
12 Imprecisely reported measurement values should be reported using “Measurement Value [statistic(measurement
name)]” columns created “on-the-fly”.
13 “Comment […]” columns (rows) can be added without restriction to a Study, Assay, Material (Investigation) file as long
as they are appropriately positioned and as long as each new “Comment […]” column (row) has a unique name for a
given file.
14 All “statistic” names must be entered in the corresponding Investigation file template “Comment [Statistic name]” row.
15 When linking to terms from ontologies, the “preferred name” should be selected and the full ID entered in the
corresponding “Term Accession Number” field.
16 “Factor Value […]” column entries are allowed to be constant.
17 Only “Parameter Value […]” column entries associated with a given “Protocol REF” column entry in a Study or Assay
file need to be constant.
18 Images should be linked to assay measurements using a new “ImageLink” file type, if the generic ISA-TAB-Nano
approach cannot be applied.
19 Any nanomaterial structure representation files, which are not associated with specific Assay file “Measurement Value
[…]” entries, should be linked to the corresponding Material file using ZIP archives specified in the appropriate
“Material Data File” column entry.
20 Empty “Factor Value […]”, “Parameter Value […]” or “Measurement Value […]” columns in Study or Assay files can be
deleted without having to update the corresponding Investigation file “Study Protocol Parameters Name”, “Study
Factor Name”, or “Study Assay Measurement Name” fields.
21 Non-applicable columns should be populated with “N/A” where this conveys information.
22 “Measurement Value [statistic(measurement name)]” columns in the templates which use a label of the form “[TO
DO:…]” for the statistic or measurement name must either be updated, based on the kind of statistic and/or
measurement name indicated by the label(s), or deleted.
aHere, the “[Study Identifier]” [37] is unique to the corresponding Study file and “[x]” denotes a numeric value which is specific to a given “true
sample”, meaning a prepared sample corresponding to a specific set of experimental conditions, in contrast to the “derived sample” concept intro-
duced in NanoPUZZLES business rule no. 10.
As well as the default behaviour of this program described
above, two command line options were specifically introduced
to enable submission of an ISA-TAB-Nano dataset developed
using these Excel templates to a database developed using the
nanoDMS software [30,107,109,110]. The first option (“-a”)
truncates all ontology identifiers: at the time of writing, “.”
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Figure 2: Schematic overview of the steps carried out by the Python program for converting Excel (“xls”) based ISA-TAB-Nano datasets to tab-delim-
ited text (“txt”) based ISA-TAB-Nano datasets. For simplicity, only one Investigation, Study, Assay and Material file (and no external file such as an
image) is included in this hypothetical dataset. In addition to the file processing steps summarised in this schematic, basic checks are carried out on
the input: (1) there should be at least one Investigation, Study, Assay and Material file; (2) there should be no duplicate column titles in a Study, Assay
or Material file other than those which are explicitly allowed by the ISA-TAB-Nano specification (e.g., “Unit”).
characters were not permitted by the nanoDMS system in
the headers of the Material, Study or Assay files, i.e., the
column heading “Characteristics [shape {NPO:http://purl.bioon-
tology.org/ontology/npo#NPO_274}]” in the Material files
generated using the default options would need to be converted
to “Characteristics [shape {NPO:NPO_274}]” etc. The second
option (“-c”) removes all “Comment […]” rows from the
Investigation file: at the time of writing, these rows would also
(indirectly) trigger errors when trying to load ISA-TAB-Nano
datasets into the nanoDMS system. The output files are auto-
matically named according to the options selected.
6 Toy dataset
In order to illustrate the use of all of the NanoPUZZLES
template files, a “Toy Dataset” was created based upon
these template files in accordance with the business rules
summarised in section 4 and discussed in detail in Supporting
Information File 4. It must be noted that the (meta)data
contained within this “Toy Dataset” are not real, although they
are based upon consideration of the nanoscience literature
[4,49,51,57,58,60,61,67,68,70,71,73,74,97,116,117]. Indeed, no
primary literature reports presenting data corresponding to all of
the templates were identified as of the time of writing. An
overview of the toy data content of this “Toy Dataset”, gener-
ated after uploading this dataset into the nanoDMS database
[110], is provided below in Figure 5 and Figure 6.
This “Toy Dataset” is available from the Supporting Informa-
tion in three versions: Supporting Information File 1 corre-
sponds to a flat archive containing files created using the orig-
inal Excel templates and saved as “xls” files; Supporting Infor-
mation File 2 is the version of this dataset created using the
default options of the Python program described in section 5;
Supporting Information File 3 was generated using the “-a” and
“-c” flags of this software. This latter version (Supporting Infor-
mation File 3) could be uploaded into the nanoDMS database
[110], which is further discussed in section 7. The following
figures provide an overview of the upload procedure for this
dataset as well as illustrating the use of the nanoDMS system
for retrieving these data: Figures 3–7.
7 Critical appraisal of the current work and
possible future directions
Some notable limitations of the NanoPUZZLES
templates and business rules introduced in this
article
The strengths and weaknesses of the manner in which the chal-
lenges associated with the generic ISA-TAB-Nano specifica-
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Figure 3: Upload options for loading the suitable version of the “Toy Dataset” (Supporting Information File 3) into the nanoDMS online database,
which can be accessed via the cited web-address [110]: ontology identifiers were truncated and Investigation “Comment […]” rows deleted, using the
Python program described in section 5, in order to enable this submission. Since these were not real data, the upload settings were selected such that
the “Toy Dataset” was not publicly visible after uploading.
Figure 4: Confirmation that the “Toy Dataset” (Supporting Information File 3) was successfully uploaded: no error messages were generated by the
internal ISA-TAB-Nano dataset validator and the warning messages regarding the position of the "Measurement Value [...]" and "Image File" columns
reflect the addition of the “Measurement Value […]” column type to ISA-TAB-Nano, as compared to ISA-TAB, Assay files.
Figure 5: A summary of the in vitro cell-based assay toy data in the “Toy Dataset” (Supporting Information File 3) generated via the nanoDMS
system. This summary can be generated via selecting the applicable dataset entry under the "Browse" menu of the nanoDMS system.
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Figure 6: A summary of the physicochemical assay toy data recorded in the “Toy Dataset” (Supporting Information File 3), generated via the
nanoDMS system as per Figure 5. This does not include the hypothetical chemical composition and nominal/vendor supplied data recorded in the Ma-
terial files.
Figure 7: Retrieving the “Toy Dataset” (Supporting Information File 3) via searching for "oxidative stress" data in the nanoDMS system.
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Table 4: Summary of some notable limitations of the NanoPUZZLES templates and business rules.
limitation no. brief description
1 Standardised reporting of stepwise sample preparation is still not handled perfectly.
2 Time dependent physicochemical characterisation data may not be perfectly captured by the templates.
3 Recording of reaction rate constants and quantum yields may need revision.
4 The manner in which chemical composition information is captured via the templates may require revision.
5 There is the possibility of information loss when mapping (raw) data reported in the literature onto predefined
“Measurement Value […]” columns.
6 The current templates are not best suited to capturing experimental data for all kinds of samples.
7 The business rules regarding multiple component “characteristics”, “factors” or “parameters” (e.g., mixtures)
may require revision.
8 The templates are not currently designed to capture data from in vivo toxicology studies.
9 Manually populating the Excel templates is time consuming and error prone.
tion (see section 2) were addressed via the templates and busi-
ness rules developed within NanoPUZZLES are discussed in
Supporting Information File 4. Beyond the need to address
these general challenges, the specific strengths and weaknesses
related to the design of the NanoPUZZLES templates (section
3) and business rules (section 4) were also discussed in section
3 and Supporting Information File 4, respectively. For example,
it was noted in section 3 (under the “Experimental Variables
Captured by the Templates” sub-section) that the manner in
which certain experimental variables are recorded using the
NanoPUZZLES templates may deviate from how other
researchers would capture these metadata using ISA-TAB-
Nano. Likewise, a possible alternative to the use of “derived
sample” identifers (introduced in NanoPUZZLES business rule
no. 10) for capturing concentration-response curve statistics,
such as an LC50 [103], and related data is presented when
discussing this business rule in Supporting Information File 4.
Table 4 summarises what are arguably the most notable
remaining challenges associated with using these resources
(templates and business rules) to collect nanotoxicology data
from the literature. An in-depth discussion of these challenges,
along with some suggestions for addressing them, is provided in
Supporting Information File 4.
Integrating data collected using the NanoPUZZLES
templates and business rules into databases
Various options currently exist, or are under development, for
submitting the ISA-TAB-Nano files generated using the
resources presented in sections 3, 4 and (if relevant) 5 to online,
searchable databases. Submission to these databases should
assist nano-QSAR researchers in identifying and retrieving data
for modelling.
One option, as discussed previously, would be to submit the
files to a database developed using the freely available “Nano-
material Data Management System” (“nanoDMS”) software
[30,107-110] which was created within the context of the
MODERN project. This database system was specifically
designed to act as a searchable, online repository for ISA-TAB-
Nano files and upload to the system is only allowed if the
internal ISA-TAB-Nano dataset validator, also available as a
standalone online tool [107], does not generate any error
messages. An existing implementation of such a database was
publicly available at the time of writing [110] and submission of
a suitably prepared version of the “Toy Dataset” described in
section 6 was successful (see Figures 3–7). However, as
discussed in section 5 and section 6, this submission would
currently require some modification of the datasets, i.e., some
ontology identifers would need to be truncated and Investi-
gation file “Comment […]” rows would need to be removed.
Another possible option would be to upload datasets generated
using these resources into the eNanoMapper database
[31,118,119]. This might be achieved via using the
eNanoMapper customisable Excel spreadsheet parser to extract
data from the Excel files created directly using the Nano-
PUZZLES templates [120]. Alternatively, it might be possible
for an ISA-TAB-Nano parser (under development within
eNanoMapper at the time of writing) to parse the tab-delimited
text files generated using the program described in section 5. In
either case the mapping of the input files onto the internal
eNanoMapper data model would be performed in a transparent
way, either explicitly via a JSON configuration file or implic-
itly by the ISA-TAB-Nano parser [31].
A brief illustration of some of the functionality of the nanoDMS
database and its use for querying data generated using the
NanoPUZZLES templates and business rules is presented in
Figures 3–7. However, it should be noted that an in-depth
discussion of the complete functionality of the nanoDMS and
eNanoMapper databases is beyond the scope of the current
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paper. Interested readers are referred to the cited references for
further details regarding the nanoDMS [30,109,110] and
eNanoMapper [31,118,119] databases.
Conclusion
There is a clear need to capture physicochemical and toxicolog-
ical nanomaterial data in consistently organised electronic
datasets which can be integrated into online, searchable data-
bases to support predictive nanotoxicology. The generic ISA-
TAB-Nano specification serves as a useful starting point for
constructing such datasets but additional guidance regarding
how to capture different kinds of (meta)data, as reported in the
nanotoxicology literature, as well as exactly which (meta)data
to record in these datasets is required. The publicly available
resources presented in the current publication are proposed as
means of (partially) addressing these requirements as well as
facilitating the creation of ISA-TAB-Nano datasets. These
resources are data collection templates, corresponding business
rules which extend the generic ISA-TAB-Nano specification,
and Python code to facilitate parsing of these datasets and inte-
gration of these datasets within other nanoinformatics resources.
Nonetheless, various challenges remain with standardised
collection of data from the nanotoxicology literature which
these resources cannot be claimed to have definitively solved
such as the need for standardised recording of stepwise sample
preparation and temporal information as well as the wider need
to achieve community consensus regarding minimum informa-
tion standards. Extension of these resources by the nanoinfor-
matics community, ideally working closely with the nanotoxi-
cology community, is anticipated to enhance their value.
Supporting Information
Please note that in addition to the following Supporting
Information files, which are versions of the “Toy Dataset”
referred to in section 6, the templates and Python program
described in this article are publicly available as previously
explained [47,114,115].
Supporting Information File 1
“Toy Dataset” (i.e., not real data) created using the data
collection templates.
[http://www.beilstein-journals.org/bjnano/content/
supplementary/2190-4286-6-202-S1.zip]
Supporting Information File 2
“Toy Dataset” converted using the Python program (default
options).
[http://www.beilstein-journals.org/bjnano/content/
supplementary/2190-4286-6-202-S2.zip]
Supporting Information File 3
“Toy Dataset” converted using the Python program (“-a”,
“-c” options).
[http://www.beilstein-journals.org/bjnano/content/
supplementary/2190-4286-6-202-S3.zip]
Supporting Information File 4
Additional documentation and discussion.
[http://www.beilstein-journals.org/bjnano/content/
supplementary/2190-4286-6-202-S4.pdf]
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